DHS Venture Partners
DHS Venture Partners is a venture capital firm comprised of Stockholm School of Economics alumni, including founders, investors, operators, and angels. They focus on supporting the next generation of great entrepreneurs by co-investing in early-stage companies. Their investment strategy centers around backing founders with innovative ideas that have the potential to scale into lasting businesses. DHS Venture Partners frequently acts as the first investor in their portfolio companies, providing ongoing support throughout their growth journeys. The firm's unique approach combines the expertise, proximity, and deep domain insight of an angel investor with the network, resources, and strength of an experienced community. With 25 selected venture partners and an active alumni group, DHS Venture Partners provides founders with access to a broad range of skills and connections. This collaborative model allows them to offer comprehensive support and guidance, increasing the chances of success for their portfolio companies. Based on portfolio data, DHS Venture Partners concentrates on pre-seed and seed stage investments. Their investment strategy is particularly focused on companies located in Sweden. By investing early and providing significant value-add through their network and expertise, DHS Venture Partners aims to build long-term relationships with founders and contribute to the growth of a vibrant entrepreneurial ecosystem.
DHS Ventures
Backing early-stage founders with Stockholm School of Economics ties to scale innovative ideas into sustainable businesses through hands-on support and vast networks.[5]
DLTG Fund
Unfortunately, the provided content is extremely sparse. It offers no information beyond the fund's name and a very high-level, single-line description. There is no multi-paragraph investment thesis or strategy description available. Without more content from the crawled pages, it is impossible to elaborate on the firm's investment strategy, specific target companies, or long-term vision.
DN Capital Group
DN Capital is a global early-stage venture firm that focuses on Seed, Series A, and select Series B opportunities in Europe and North America. Founded in 2000, the firm has offices in London, Berlin, and San Francisco. They seek to back outstanding entrepreneurs building globally impactful businesses by providing not only capital but also leveraging their extensive global network and financial expertise to give portfolio companies the best possible platform for growth. DN Capital invests with investment rigour at all stages, committed to openness and integrity, and aims to work as hard as the entrepreneurs to build their businesses. The firm believes in the power of disruptive technologies and actively seeks out companies disrupting industries. DN Capital positions themselves as partners who take building your business as seriously as the founders do, illustrated by testimonials highlighting their proactive approach, business development opportunities, and strategic guidance. They also demonstrate a transatlantic focus, believing in the vision to build global category leaders. DN Capital concentrates its investments in four key sectors: Software, AI, Fintech, and Consumer Internet. Their historical success is evidenced by their backing of category leaders in these verticals. The firm's longevity and multiple exits demonstrate their ability to identify and support companies from early stages through successful outcomes. They aim to provide portfolio companies with up to €20m of capital and are always excited to receive business plans from entrepreneurs seeking capital. Their backing by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Stra highlights their European roots and commitment to innovation within the region.
DNV
DNV Ventures invests in startups that align with DNV’s purpose of safeguarding life, property, and the environment. They aim to partner with founding teams that address global challenges rising in the energy transition and the fourth industrial revolution. They focus on tackling global transformations through investments. The fund is also exploring Trust in AI landscape.
DOEN Ventures
Stichting DOEN versnelt de transitie naar een circulaire, inclusieve economie door initiatieven te ondersteunen die gemeenschappelijkheid en radicale verbeelding bevorderen. Het fonds richt zich op drie thema’s: regeneratieve economie (groen), solidaire samenleving (sociaal) en veranderkracht van verbeelding (creatief). DOEN biedt een vliegende start aan voorlopers die anderen kunnen inspireren met duurzame en inclusieve oplossingen.
DOMO.VC
DOMO.VC is a Brazilian Venture Capital firm focused on investing in early-stage technology startups across Latin America. Their investment thesis centers around identifying and supporting disruptive and innovative founders with the potential to transform their respective markets. The firm aims to be more than just a capital provider, positioning itself as a platform to help startups grow and establish themselves. With over 20 years of experience in founding, investing, and advising technology startups, DOMO.VC seeks to transform potential into success and contribute to the development of the tech ecosystem in Latin America. They invest in companies demonstrating strong potential for growth and market leadership, offering not only capital but also strategic guidance and operational support. The firm's partners have experience as entrepreneurs, including founding Buscapé in Brazil. Furthermore, they have a history of investing in successful startups like Loggi, Gympass, Hotmart, Descomplica, and Quero Educação, indicating a strong track record in identifying and supporting high-growth companies. DOMO.VC embraces a collaborative approach, acting as a partner to the startups they invest in, and providing them with the resources and expertise needed to scale their businesses. The fund's manifest emphasizes its role as a "fortress for transformative entrepreneurs," a "nurturing environment for those who dare to dream," and a "catalyst for success."
DQuadrat Equity Partner
Based on the website content, DQuadrat Equity Partner doesn't appear to be a venture capital firm in the traditional sense. Instead, it seems to be a creative agency and manufacturer specializing in concept design, decoration, and event planning. Their approach centers around boundless creativity, emphasizing the integration of trends from fashion, architecture, lifestyle, and design to create captivating and unique experiences. They focus on crafting concepts that resonate emotionally, delivering impactful messages, and stimulating imagination through comprehensive spatial design. The company values teamwork, innovation, and continuous development. Founded by two creative individuals, DQuadrat fosters a dynamic team environment where individual talents in areas such as decoration, woodworking, advertising, product design, floristry, planning, digital printing, and tailoring are combined to achieve inspiring results. Their core services include concept and planning, print and advertising technology, graphic design, event decoration, creative process development, center decoration, trade fair decoration, custom constructions, and floristry. They operate online stores like dquadrat-stores.de and tee-undkraeutergalerie.de, suggesting retail or e-commerce aspects within their business model.
DRONE FUND
A drone-focused venture capital firm aiming to build a 'drone-premise society' by 2050. Invests in domestic and international drone startups across hardware, software, and core technologies to accelerate the adoption of drone and air mobility solutions.
Dai-ichi Life Insurance Company
Based on the provided information, it's difficult to formulate a comprehensive investment thesis and strategy description for Dai-ichi Life Insurance Company as a VC firm. The data suggests that Dai-ichi Life engages in venture capital activities, but the scope and scale of those activities are not explicitly outlined in the crawled web pages. Their VC activities are evident from the 2008 news release regarding the "ベンチャーキャピタル事業における共同事業の強化について" (Strengthening of joint projects in the venture capital business). However, details on specific investment areas, target companies, or the firm's overall investment approach are lacking from the available information. From the news releases, they appear to be investing in funds and projects related to healthcare, elderly care, and other social welfare-related sectors.
Danieli
Based on the provided content, it is difficult to determine the firm's overall investment thesis and strategy as Maddyness appears to be primarily a news media outlet covering the French tech and startup ecosystem. The portfolio section of Maddyness highlights various startups and funds, but it doesn't explicitly outline Danieli's investment philosophy or approach. We can infer that their strategy likely involves early-stage investing given the focus on startups. However, without more information, it's impossible to provide a detailed summary. Maddyness is dedicated to helping entrepreneurs find the right investor by providing portraits of different funds. This suggests an informational role rather than a direct investment summary.
Danish BioInnovation Institute
Danish BioInnovation Institute (BII) is a venture capital firm focused on supporting early-stage start-ups and spin-out companies within human health, planetary health, and societal resilience. They aim to translate scientific breakthroughs into innovative products and solutions. BII provides funding, lab and office space, and comprehensive support to help entrepreneurs accelerate their journey towards validated ventures and company creation. Their programs include Venture Lab, Bio Studio, and Quantum Lab, each tailored to specific stages and areas of innovation. They actively foster a community where scientific discoveries can be transformed into viable businesses, contributing to a better world by addressing pressing global challenges in health and sustainability. They provide access to state-of-the-art laboratories, resources, and support systems to ensure their portfolio companies have the environment to thrive and develop cutting-edge technologies and solutions. BII operates through a series of focused programs designed to support start-ups at various stages. The Venture Lab program is for early-stage start-ups providing up to DKK 4M in funding to accelerate venture validation. The Bio Studio program supports entrepreneurial academic researchers in translating their science into innovative products and solutions, offering up to DKK 5.35M funding per year for three years. The Quantum Lab focuses on early-stage quantum technology startups in collaboration with NATO DIANA. In addition to funding, BII provides access to fully equipped laboratories, office spaces, and other essential infrastructure, allowing companies to focus on their research and development. BII's approach extends beyond mere financial investment. They provide extensive support services, including waste management, access to basic laboratory gases, consumables, and equipment, autoclaving and dishwashing services, and cryo/freezer storage space. They also assist with regulatory compliance, such as advising on work related to genetically modified organisms. This holistic support system is designed to minimize operational burdens and maximize the efficiency of their portfolio companies. By combining funding, facilities, and expertise, BII aims to create an ecosystem where innovation can flourish and impactful solutions can be developed and brought to market. BII demonstrates its commitment to creating societal impact through focusing its investments in areas critical to the future, such as human health, planetary health, and societal resilience. This is further supported by their collaborative environment in which portfolio companies can collaborate and leverage on shared knowledge and facilities. This is enhanced by the dedicated program support, specifically tailored to the needs of the different stages of growth and innovation. In addition, BII provides access to expert guidance, equipment, and facilities that enable the development and validation of novel technologies. By actively seeking and supporting changemakers, BII fosters an ecosystem conducive to the growth of innovative start-ups and spin-outs capable of addressing complex global challenges. They have achieved substantial traction, having supported 131 start-ups to date and contributing to the launch of 21 products on the market. With €139M in total funding and a portfolio that has collectively raised €1B in external funding, BII underscores its role as a significant catalyst for bioinnovation and a valuable partner for entrepreneurs seeking to translate scientific ideas into tangible solutions.
Danish Industry Foundation (Industriens Fond)
Industriens Fond (the Danish Industry Foundation) supports projects that benefit Danish companies. Their primary focus is on creating and applying new knowledge within the Danish business sector, viewing it as a fundamental driver for growth. They aim to ensure companies have access to employees with the necessary knowledge and skills to foster growth, emphasizing the importance of innovation to empower SMEs and entrepreneurs, granting them access to new markets and opportunities. The foundation achieves this through providing knowledge, developing competencies and fostering innovation in Danish businesses.
De Nora
Invests in early-stage technologies and startups in electrochemical, water treatment, and energy transition sectors to drive strategic innovation and sustainable growth.
DeBa Ventures
DeBa Ventures is a venture capital firm focused on discovering, supporting, and promoting founders crafting the future of fintech. They are more than just investors; they aim to be partners in shaping the future of the fintech industry by seeking out passionate entrepreneurs solving real-world problems through innovation. The firm emphasizes a founder-driven approach, leveraging the experience of their team, which includes successful exited entrepreneurs and seasoned fund managers. They provide tailored mentorship and strategic support, recognizing the unique challenges startups face. DeBa Ventures offers flexible investment models and fosters a collaborative partnership through their network of experts and advisors, combined with regular strategic sessions. Their investment strategy is global and prioritizes fintech companies, along with B2B, AI and SaaS, reflecting a commitment to fostering innovation in these dynamic sectors without geographical limitations. They believe in nurturing innovation and building a collaborative journey with visionary founders. The firm's mission is to uncover, nurture, and elevate the entrepreneurs shaping the future. DeBa Ventures distinguishes itself with a unique shared success model, allocating 10% of their profits back to the employees of their portfolio companies, acknowledging their contributions to collective achievements and growth. This policy reflects their belief in rewarding dedication and hard work, creating a mutually beneficial partnership. They measure their achievements by the great entrepreneurs they partner with, highlighting their portfolio's forward-looking companies.
Debiopharm Innovation Fund
Debiopharm Innovation Fund invests in digital health and smart data start-ups with the aim to improve patient outcomes and quality of life, particularly in oncology and infectious diseases. They seek to establish tomorrow's standard of care by enabling innovation in drug development, drug manufacturing, and digital health. The fund focuses on companies applying AI and data-driven insights to accelerate clinical trials, improve patient outcomes, and enhance drug discovery. They aim to leverage new imaging digital biomarkers from longitudinal images to help Debiopharm accelerate time to market and improve success rates of clinical trials, and are exploring digital twins for use in virtual control arms. The fund invests in areas that can significantly reduce the time and costs of clinical trials, more accurately predict patient outcomes, or enhance drug discovery using AI and data analytics. They are interested in platforms that can acquire imaging data from trial sites and generate clinically meaningful predictions from imaging data. Additionally, they seek opportunities in areas like collaborative software platforms for expanded access to medicines, cancer data aggregation and analytics platforms for precision oncology, and privacy-preserving data collaboration platforms. Debiopharm's investment strategy is driven by a desire to positively contribute to society and the environment through corporate responsibility. The fund supports projects and works that aim at improving the quality of life for patients. They actively seek out entrepreneurs with ambitions to take their professional endeavors to the next level and provide funding and support to help them achieve their goals. They appear to be interested in solutions related to in-vivo study design, AI-driven data cleaning, precision medicine in radiology, AI for clinical teams and multimodal AI models for histology images.
Decasonic
Decasonic is a venture and digital assets fund focused on building blockchain and AI innovation. They invest in early-stage companies in the Web3 and AI supercycle, emphasizing a product-first and thesis-driven approach. The firm aims to partner closely with founders building durable companies through periods of technological and market change. They draw on decades of experience as tech investors and operators to help founders in blockchain accelerate product-market fit and scale growth. The firm believes that blockchain and AI are at a similar stage as the internet in 2000 and that tomorrow's killer apps represent trillion-dollar opportunities. Decasonic seeks to partner with outlier founders who generate 100x+ outcomes. They operate like outlier founders, demonstrating dedication to building blockchain and AI innovation.
Decelera Ventures
Decelera invests in resilient, visionary founders who demonstrate leadership and potential to build scalable, impactful companies. Their founder-centric approach combines capital with hands-on support (e.g., a 12-month decelerator program in Menorca) to foster sustainable growth and ecosystem impact across Europe. Focused on validating business models and team readiness, Decelera targets 50+ companies annually with €38M in capital.
Declaration Partners
Declaration Partners aims to create value in private investments through deep sector expertise, differentiated access, and authentic partnerships, rooted in a family office heritage. They emphasize long-term partnership alignment to optimize shared outcomes, focusing on flexible capital deployment to achieve superior returns over the long term. Their strategies span Private Investments, Real Estate, and GP Solutions, reflecting a diversified approach to value creation. The firm is anchored by David M. Rubenstein and partners with like-minded entrepreneurs, operators, and investors to create the "next generation" of value. In Private Investments, the objective is to capture asymmetric upside from attractive growth companies across various economic cycles. The Real Estate strategy seeks to combine family office flexibility with institutional real estate experience to generate attractive risk-adjusted returns. The GP Solutions strategy appears to focus on assisting talented investors and entrepreneurs in building their firms. Declaration Partners highlights its family heritage, entrepreneurial mindset, investment flexibility, and long-term alignment as key advantages. They also emphasize their experienced investment team with sub-sector expertise, supported by an institutional investment management infrastructure, as well as their global network of entrepreneurs, executive relationships, and senior capital markets participants. Partnership, reputation, and integrity are also listed as core values. Overall, the firm's investment thesis appears to be centered on leveraging its family office roots, sector expertise, and extensive network to identify and partner with high-potential companies and investment managers across various asset classes, while prioritizing long-term value creation and alignment of interests.
Deep Capital
Deep Capital Group invests in disruptive technologies and problem-solving ventures that drive systemic change, prioritizing sustainability, social responsibility, and long-term impact over short-term gains. The firm targets underserved sectors and supports entrepreneurs who challenge industry paradigms with ethical, innovative, and scalable solutions.
Deep Science Ventures
Deep Science Ventures combines scientific expertise with founder-type scientists to create ventures that address critical challenges in agriculture, computation, climate, pharma, and education, aiming for a future where humanity and the planet thrive.
DeepTech & Climate Fund (DTCF)
DeepTech & Climate Fund (DTCF) invests in visionary companies driving breakthrough innovation and the transformation of the economy. As a long-term investor, they partner with entrepreneurs and other investors to back the technology champions of tomorrow. They focus on companies with long development cycles, deep technology roots, and bold visions, aiming to strengthen Europe's global competitiveness. DTCF provides capital, expertise, and strategic support to navigate complex growth journeys and reach international markets. They build bridges between high-tech startups, SMEs, and long-term-oriented investors to drive sustainable success. The fund's goal is to be a long-term partner for transformative innovation throughout every growth stage, supporting companies to scale through buy-and-build strategies, enter new markets, and design future-ready exit paths.
DeepTechXL
DeepTechXL specializes in deep-tech investments, leveraging expertise and networks from leading tech corporates, knowledge institutes, and impact investors to accelerate time-to-market for deep-tech ventures through access to resources, technologies, licenses, supply chain partners, and co-investors.
DeepWater
Information not available.